Markets
Stocks
Mutual Funds & ETF's
Sectors
Tools
Overview
Market News
Currencies
International
Search InvestCenter
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Top Indices
DJI
Nasdaq Composite
SPX
My Portfolio
Uniqure Ord Shs
(NQ:
QURE
)
7.625
-0.115 (-1.49%)
Streaming Delayed Price
Updated: 4:00 PM EDT, Jul 22, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
Price and Volume
Detailed Quote
Volume
1,344,401
Open
7.720
Bid (Size)
7.450 (1)
Ask (Size)
7.700 (2)
Prev. Close
7.740
Today's Range
7.260 - 7.810
52wk Range
3.730 - 11.35
Shares Outstanding
48,549,437
Dividend Yield
N/A
Intraday
1 Week
1 Month
3 Month
1 Year
3 Year
5 Year
Top News
More News
Why ConAgra Brands Shares Are Trading Lower? Here Are Other Stocks Moving In Thursday's Mid-Day Session
July 11, 2024
Via
Benzinga
Why Are UniQure Shares Surging Today?
July 10, 2024
UniQure N.V. (NASDAQ: QURE) shares are skyrocketing Wednesday following the release of promising interim data from its Phase I/II clinical trials of AMT-130, a gene therapy targeting Huntington's...
Via
Benzinga
Performance
YTD
+10.03%
+10.03%
1 Month
+66.12%
+66.12%
3 Month
+58.20%
+58.20%
6 Month
+33.77%
+33.77%
1 Year
-21.63%
-21.63%
More News
Read More
Why SeaStar Medical Holding Shares Are Trading Lower By Around 34%? Here Are Other Stocks Moving In Wednesday's Mid-Day Session
July 10, 2024
Via
Benzinga
Recap: uniQure Q4 Earnings
February 28, 2024
Via
Benzinga
SMART Global Posts Upbeat Results, Joins Aehr Test Systems, MarineMax And Other Big Stocks Moving Higher On Wednesday
July 10, 2024
Via
Benzinga
Kura Sushi Posts Weak Q3 Results, Joins LegalZoom.com And Other Big Stocks Moving Lower In Wednesday's Pre-Market Session
July 10, 2024
Via
Benzinga
S&P 500 Edges Higher; Indivior Shares Plummet
July 09, 2024
Via
Benzinga
Topics
Stocks
Exposures
US Equities
Why Helen of Troy Shares Are Trading Lower By Around 30%? Here Are Other Stocks Moving In Tuesday's Mid-Day Session
July 09, 2024
Via
Benzinga
Crude Oil Down 1%; Soligenix Shares Surge
July 09, 2024
Via
Benzinga
Exposures
Fossil Fuels
Why UniQure Stock Is Soaring
July 09, 2024
Via
Benzinga
MULN Stock Alert: Mullen Announces EV Sale to Spencer Manufacturing
July 09, 2024
Via
InvestorPlace
Why Is uniQure (QURE) Stock Up 51% Today?
July 09, 2024
Via
InvestorPlace
Dow Falls Over 50 Points; US Small Business Optimism Surges In June
July 09, 2024
Via
Benzinga
Topics
Stocks
Exposures
US Equities
uniQure Announces Positive Interim Data Update Demonstrating Slowing of Disease Progression in Phase I/II Trials of AMT-130 for Huntington’s Disease
July 09, 2024
From
uniQure Inc.
Via
GlobeNewswire
uniQure Announces Sale of Commercial Manufacturing Facility to Genezen
July 01, 2024
From
uniQure Inc.
Via
GlobeNewswire
uniQure Receives FDA Regenerative Medicine Advanced Therapy (RMAT) Designation for Investigational Gene Therapy AMT-130 in Huntington’s Disease
June 03, 2024
From
uniQure Inc.
Via
GlobeNewswire
QURE Stock Earnings: uniQure Misses EPS, Beats Revenue for Q1 2024
May 07, 2024
Via
InvestorPlace
uniQure Announces First Quarter 2024 Financial Results and Highlights Recent Company Progress
May 07, 2024
From
uniQure Inc.
Via
GlobeNewswire
Pfizer Now Rivals The World's Most Expensive Medicine After FDA Approves Gene Therapy
April 26, 2024
Via
Investor's Business Daily
Exposures
Product Safety
AMD To Rally Around 16%? Here Are 10 Top Analyst Forecasts For Monday
March 04, 2024
Via
Benzinga
uniQure Announces 2023 Financial Results and Highlights Recent Company Progress
February 28, 2024
From
uniQure Inc.
Via
GlobeNewswire
Why Butterfly Network Shares Are Trading Lower By 22%? Here Are Other Stocks Moving In Thursday's Mid-Day Session
February 29, 2024
Via
Benzinga
Why Compugen Shares Are Trading Higher By Over 200%? Here Are Other Stocks Moving In Tuesday's Mid-Day Session
December 19, 2023
Via
Benzinga
Bluebird Bio, Vertex Energy And Other Big Stocks Moving Lower On Tuesday
December 19, 2023
Via
Benzinga
Topics
Stocks
Exposures
US Equities
uniQure Announces Update on Phase I/II Clinical Trials of AMT-130 Gene Therapy for the Treatment of Huntington’s Disease
December 19, 2023
From
uniQure Inc.
Via
GlobeNewswire
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.